tradingkey.logo

Park Ha Biological Technology Co Ltd

PHH
0.396USD
0.000
Fechamento 10/21, 16:00ETCotações atrasadas em 15 min
11.62MValor de mercado
--P/L TTM

Park Ha Biological Technology Co Ltd

0.396
0.000

Mais detalhes de Park Ha Biological Technology Co Ltd Empresa

Park Ha Biological Technology Co Ltd is an investment holding company primarily engaged in developing private skincare label, direct skincare products sales and franchise alliances promotions. The Company mainly operates its business through two segments. The Products Sales segment is engaged in providing skincare and cosmetic products under the brand name Park Ha as well as offering complimentary after-sales beauty services in physical stores. The Franchise Service segment is engaged in entering franchise agreements with its franchisees, pursuant to which the franchisees are granted permission to open and operate a store under the brand name Park Ha or Geni. The Company's products include Little Blue Injection Serum, Parkha Amino Acid Cleansing Foam and other products. The Company mainly conducts its business in domestic market.

Informações de Park Ha Biological Technology Co Ltd

Código da empresaPHH
Nome da EmpresaPark Ha Biological Technology Co Ltd
Data de listagemDec 27, 2024
CEOMs. Xiaoqiu Zhang
Número de funcionários31
Tipo de títulosOrdinary Share
Fim do ano fiscalDec 27
Endereço14F, Building 3
CidadeWUXI
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísChina
Código postal214135
Telefone864000127562
Sitehttp://ir.parkha.cn/
Código da empresaPHH
Data de listagemDec 27, 2024
CEOMs. Xiaoqiu Zhang

Executivos da empresa Park Ha Biological Technology Co Ltd

Nome
Nome/Posição
Posição
Ações detidas
Variação
Ms. Xiaoqiu Zhang
Ms. Xiaoqiu Zhang
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Ms. Xiaoyan Zhu
Ms. Xiaoyan Zhu
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Xinyu Li
Ms. Xinyu Li
Chief Technology Officer, Product Manager
Chief Technology Officer, Product Manager
--
--
Ms. Li Wang
Ms. Li Wang
Director
Director
--
--
Ms. Yanan Shan
Ms. Yanan Shan
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Qixiong Sheng
Mr. Qixiong Sheng
Independent Director
Independent Director
--
--
Mr. Xiaozhong Yu
Mr. Xiaozhong Yu
Independent Director Nominee
Independent Director Nominee
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Ms. Xiaoqiu Zhang
Ms. Xiaoqiu Zhang
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Ms. Xiaoyan Zhu
Ms. Xiaoyan Zhu
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Xinyu Li
Ms. Xinyu Li
Chief Technology Officer, Product Manager
Chief Technology Officer, Product Manager
--
--
Ms. Li Wang
Ms. Li Wang
Director
Director
--
--
Ms. Yanan Shan
Ms. Yanan Shan
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Qixiong Sheng
Mr. Qixiong Sheng
Independent Director
Independent Director
--
--

Detalhamento da receita

FY2024
FY2023
FY2022
FY2021
Sem dados
Por RegiãoUSD
Nome
Receita
Proporção
China (Mainland)
2.38M
0.00%
Por Empresa
Por Região
Sem dados

Distribuição de ações

Atualizado em: sáb, 23 de ago
Atualizado em: sáb, 23 de ago
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Xiaoqiu Holding Ltd
56.24%
Changxin International Ltd Partnership
7.38%
Citadel Advisors LLC
0.06%
Invesco Capital Management LLC
0.06%
Geode Capital Management, L.L.C.
0.05%
Outro
36.21%
Investidores
Investidores
Proporção
Xiaoqiu Holding Ltd
56.24%
Changxin International Ltd Partnership
7.38%
Citadel Advisors LLC
0.06%
Invesco Capital Management LLC
0.06%
Geode Capital Management, L.L.C.
0.05%
Outro
36.21%
Tipos de investidores
Investidores
Proporção
Corporation
63.62%
Investment Advisor
0.13%
Research Firm
0.10%
Hedge Fund
0.07%
Investment Advisor/Hedge Fund
0.05%
Outro
36.04%

Participação acionária institucional

Atualizado em: qua, 1 de out
Atualizado em: qua, 1 de out
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q3
15
115.17K
0.34%
+64.73K
2025Q2
9
21.62M
81.98%
-25.58K
2025Q1
8
21.60M
81.90%
-29.47K
2024Q4
6
21.63M
82.55%
+21.63M

Atividade dos acionistas

Nome
Ações detidas
Proporção
Variação
Var. %
Data
Xiaoqiu Holding Ltd
19.05M
56.24%
--
--
Feb 24, 2025
Changxin International Ltd Partnership
2.50M
7.38%
--
--
Feb 24, 2025
Citadel Advisors LLC
21.23K
0.06%
+4.63K
+27.87%
Jun 30, 2025
Invesco Capital Management LLC
20.61K
0.06%
+20.61K
--
Jun 30, 2025
Geode Capital Management, L.L.C.
16.85K
0.05%
+69.00
+0.41%
Jun 30, 2025
State of Wyoming
12.02K
0.04%
+12.02K
--
Jun 30, 2025
BNP Paribas Securities Corp. North America
12.03K
0.04%
+12.03K
--
Jun 30, 2025
Scientech Research LLC
8.35K
0.02%
+8.35K
--
Jun 30, 2025
Morgan Stanley & Co. LLC
7.03K
0.02%
+7.03K
--
Jun 30, 2025
Scotia Capital Inc.
6.00K
0.02%
+6.00K
--
Jun 30, 2025
Ver Mais

ETFs Relacionados

Atualizado em: seg, 6 de out
Atualizado em: seg, 6 de out
Nome
Proporção
Invesco Golden Dragon China ETF
0.01%
Invesco Golden Dragon China ETF
Proporção0.01%

Dividendo

Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados

Desdobramento de ações

Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
KeyAI